Theravance Biopharma
Price & Volume
Stats
See more52W Range | $7.90-$18.96 |
Market Cap | $909.5M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $80.3M |
Revenue Growth (YoY) | 18.5% |
Gross Profit (12 Mos) | $40.8M |
Diluted EPS | $0.57 |
News
See moreYahoo Finance • 3 months ago
Theravance Biopharma stock rating reiterated at Buy by BTIG
Yahoo Finance • 3 months ago
Theravance anticipates $150M in milestones as CYPRESS trial nears pivotal data readout
Yahoo Finance • 3 months ago
Theravance Biopharma Q2 2025 slides: Revenue jumps 22%, cash position triples
Yahoo Finance • 4 months ago
Theravance Biopharma SVP Farnum sells $113,869 in stock
About
CEO | Mr. Rick E. Winningham M.B.A. |
CFO | Mr. Aziz Sawaf C.F.A. |
Address | 901 Gateway Boulevard, South San Francisco, CA, United States, 94080 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 97 |
